Critics addressed the elephant in the room during the FDA’s first public meeting on trauma since its decision to delay ...

The post A Setback for MDMA-Assisted Psychotherapy appeared first on Reason.com. Autoblog chats to a hardcore Mustang fan and ...

The FDA rejected MDMA-assisted therapy for PTSD. SetSet's April Pride calls for harm-reduction education and regulatory ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

As Psychiatric Times reported, this decision puts on hold what could have been a landmark approval for the treatment of PTSD with MDMA, also known as midomafetamine. Despite the setback, Lykos ...

In a previous blog on the use of psychedelics to treat mental health disorders, we reported that the US Food and Drug ...

Delve into the psychedelic-assisted therapy market and investors' sentiment after the FDA's decision about Lykos' MDMA ...

Amy Emerson is stepping down on the heels of the FDA last month rejecting Lykos Therapeutics’ MDMA-based therapy for ...

The US Food and Drug Administration's (FDA) decision not to approve midomafetamine-assisted therapy (MDMA-AT) for ...

The CEO's departure comes after Lykos co-founder and longtime psychedelic medicines advocate Rick Doblin stood down from the ...

The Food and Drug Administration’s (FDA) recent rejection of midomafetamine (MDMA), along with mental health therapy, for the treatment of post-traumatic stress disorder (PTSD) came as no surprise.

Advocates are pushing for approval of psychedelic-assisted therapy from the FDA, seeking a means of therapy without fear of ...